C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2011
08/23/2011	US8003595 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
08/23/2011	US8003386 Tumor necrosis factor receptors 6α and 6β
08/23/2011	US8003382 Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof
08/23/2011	US8003362 Methods and constructs for high yield expression of clostripain
08/23/2011	US8003351 Activatable recombinant neurotoxins
08/23/2011	US8003347 Nucleic acids encoding ChemerinR ligands
08/23/2011	US8003346 Mutant PCNA
08/23/2011	US8003334 Methods for identifying compounds which bind to TANGO294
08/23/2011	US8003109 Pharmaceutical compositions containing the long pentraxin PTX3
08/23/2011	US8003104 Method for treating inflammation
08/23/2011	US8003101 Inflammatory mediator antagonists
08/23/2011	US8003100 Antibodies that bind to 238P1B2
08/23/2011	US8003075 Diagnostic assay for human matrix GLA-protein and its use as a biomarker
08/23/2011	CA2574929C Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions
08/23/2011	CA2574092C Dna coding for polypeptide participating in biosynthesis of pladienolide
08/23/2011	CA2516018C Hepatitis c inhibitor peptide analogs
08/23/2011	CA2481504C Enhanced silk exsertion under stress
08/23/2011	CA2469053C Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
08/23/2011	CA2442159C Treatment using neublastin polypeptides
08/23/2011	CA2428278C Virulence of streptococci
08/23/2011	CA2377209C Therapeutic peptide-based constructs
08/23/2011	CA2358107C Shelf-stable formulation of glucagon-like peptide-1
08/23/2011	CA2342397C Genes from a gene cluster
08/23/2011	CA2335488C Conformationally constrained backbone cyclized somatostatin analogs
08/23/2011	CA2324478C A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
08/23/2011	CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor
08/23/2011	CA2270877C Peptide-based immunotherapeutic agent
08/23/2011	CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
08/23/2011	CA2216098C Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution
08/23/2011	CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
08/23/2011	CA1341620C Envelope antigens of hiv-1
08/18/2011	WO2011100468A2 Methods and materials for treating cancer
08/18/2011	WO2011100362A1 Modified adam disintegrin domain polypeptides and uses thereof
08/18/2011	WO2011099783A9 Method for producing cell growth factors from adipose-derived stem cells and monocytes and applications thereof
08/18/2011	WO2011099783A2 Method for producing cell growth factors from adipose-derived stem cells and monocytes and applications thereof
08/18/2011	WO2011099721A2 Composition for inducing the maturation of dendritic cells
08/18/2011	WO2011099566A1 Antibody against mucin 1 (muc1) protein and use of same
08/18/2011	WO2011098962A2 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer
08/18/2011	WO2011098772A1 Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
08/18/2011	WO2011098652A1 Applications of the protein muns and the derivates thereof
08/18/2011	WO2011098484A1 Trichodysplasia spinulosa- associated polyomavirus (tsv)
08/18/2011	WO2011098400A1 Igf-i poly (ethylene glycol) conjugates
08/18/2011	WO2011098095A1 Peptides binding the tpo receptor
08/18/2011	WO2011097816A1 Dep2, a dense and erect panicle gene and uses thereof
08/18/2011	WO2011097713A1 Carbohydrate binding modules with reduced binding to lignin
08/18/2011	WO2011076903A9 Mutant nisin ser 29 derivatives and the use thereof
08/18/2011	WO2011068953A9 Atoxic recombinant holotoxins of clostridium difficile as immunogens
08/18/2011	WO2011064437A3 Viral vectors and methods used in the preparation of gdnf
08/18/2011	WO2011057254A3 Simian adenoviral vector-based vaccines
08/18/2011	WO2011056975A9 Genetically encoded calcium indicators and methods of use
08/18/2011	WO2011029008A3 Synbodies to akt1
08/18/2011	WO2011028963A3 Immunogenic hiv composition
08/18/2011	WO2011006644A9 Process for the production of exenatide and of an exenatide analogue
08/18/2011	WO2005069762A8 Bacillus licheniformis chromosome
08/18/2011	US20110203016 Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein
08/18/2011	US20110203015 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE
08/18/2011	US20110203014 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use
08/18/2011	US20110202281 Adaptive biochemical signatures
08/18/2011	US20110201816 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
08/18/2011	US20110201798 Therapeutic compositions
08/18/2011	US20110201796 DNA sequence in plant caragana jubata with freeze tolerance
08/18/2011	US20110201785 Method for optimizing proteins having the folding pattern of immunoglobulin
08/18/2011	US20110201784 Functionalized cyanine having a silane linker arm, a method of preparing thereof and uses thereof
08/18/2011	US20110201783 Apparatus for the Preparation of a Thread From Silk Proteins
08/18/2011	US20110201782 Novel human genes relating to respiratory diseases and obesity
08/18/2011	US20110201781 Cysteine labeling system and method of use thereof
08/18/2011	US20110201780 Novel death domain proteins
08/18/2011	US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same
08/18/2011	US20110201670 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
08/18/2011	US20110201560 Peptides for inhibiting the hpv-e6 oncoprotein
08/18/2011	US20110201547 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
08/18/2011	US20110201518 Healthy kidney biomarkers
08/18/2011	US20110201118 Nuclease activity of tal effector and foki fusion protein
08/18/2011	US20110201107 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
08/18/2011	US20110201105 Lactation-associated polypeptides
08/18/2011	US20110201080 Biomolecules having multiple attachment moieties for binding to a substrate surface
08/18/2011	US20110201055 Engineered cleavage half-domains
08/18/2011	US20110201052 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
08/18/2011	US20110201051 Chemosensory gene family encoding gustatory and olfactory receptors and uses thereof
08/18/2011	US20110201046 T1r hetero-oligomeric taste receptors
08/18/2011	US20110201044 Tuberculosis diagnostic test
08/18/2011	US20110201035 Compositions and methods for the detection of hiv-1/hiv-2 infection
08/18/2011	US20110201030 Human G-Protein Chemokine Receptor (CCR5) HDGNR10
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110201020 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
08/18/2011	US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B
08/18/2011	US20110200638 Bacterial vaccine
08/18/2011	US20110200637 Immunizing Compositions and Methods of Use
08/18/2011	US20110200631 Lawsonia intracellularis vaccines
08/18/2011	US20110200630 Live attenuated virus vaccines for la crosse virus and other bunyaviridae
08/18/2011	US20110200628 Chimeric Proteins that Induce Effects Directed Against Viruses
08/18/2011	US20110200624 Novel peptides for use in transfection
08/18/2011	US20110200616 Immunizing Compositions and Methods of Use
08/18/2011	US20110200614 Anthrax specific antibodies
08/18/2011	US20110200605 Polypeptides and use thereof
08/18/2011	US20110200603 New antigens for paratuberculosis diagnosis and vaccination
08/18/2011	US20110200562 Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use
08/18/2011	US20110200560 Non-ionic self-assembling peptides and uses thereof
08/18/2011	US20110200555 Conjugates of hydroxyalkyl starch and a protein
08/18/2011	US20110200552 Cytokine design

1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 2916